University/BHF Centre for Cardiovascular Science, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh BioQuarter, Edinburgh, United Kingdom.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Elife. 2023 Apr 25;12:e88080. doi: 10.7554/eLife.88080.
Caloric restriction (CR) reduces the risk of age-related diseases in numerous species, including humans. CR's metabolic effects, including decreased adiposity and improved insulin sensitivity, are important for its broader health benefits; however, the extent and basis of sex differences in CR's health benefits are unknown. We found that 30% CR in young (3-month-old) male mice decreased fat mass and improved glucose tolerance and insulin sensitivity, whereas these effects were blunted or absent in young females. Females' resistance to fat loss was associated with decreased lipolysis, energy expenditure and fatty acid oxidation, and increased postprandial lipogenesis, compared to males. The sex differences in glucose homeostasis were not associated with differential glucose uptake but with altered hepatic ceramide content and substrate metabolism: compared to CR males, CR females had lower TCA cycle activity and higher blood ketone concentrations, a marker of hepatic acetyl-CoA content. This suggests that males use hepatic acetyl-CoA for the TCA cycle whereas in females it accumulates, stimulating gluconeogenesis and limiting hypoglycaemia during CR. In aged mice (18-months old), when females are anoestrus, CR decreased fat mass and improved glucose homeostasis similarly in both sexes. Finally, in a cohort of overweight and obese humans, CR-induced fat loss was also sex- and age-dependent: younger females (<45 years) resisted fat loss compared to younger males while in older subjects (>45 years) this sex difference was absent. Collectively, these studies identify age-dependent sex differences in the metabolic effects of CR and highlight adipose tissue, the liver and oestrogen as key determinants of CR's metabolic benefits. These findings have important implications for understanding the interplay between diet and health, and for maximising the benefits of CR in humans.
热量限制(CR)可降低包括人类在内的许多物种与年龄相关疾病的风险。CR 的代谢作用,包括减少肥胖和提高胰岛素敏感性,对其更广泛的健康益处很重要;然而,CR 对健康益处的性别差异的程度和基础尚不清楚。我们发现,年轻(3 个月大)雄性小鼠的 30%CR 可减少脂肪量并改善葡萄糖耐量和胰岛素敏感性,而这些作用在年轻雌性小鼠中减弱或不存在。与雄性相比,雌性对脂肪减少的抵抗力与脂解作用降低、能量消耗和脂肪酸氧化减少以及餐后脂肪生成增加有关。葡萄糖稳态的性别差异与葡萄糖摄取的差异无关,而是与肝脏神经酰胺含量和底物代谢有关:与 CR 雄性相比,CR 雌性的 TCA 循环活性较低,血液酮体浓度较高,这是肝乙酰辅酶 A 含量的标志物。这表明雄性将肝乙酰辅酶 A 用于 TCA 循环,而在雌性中则积累,从而在 CR 期间刺激糖异生并限制低血糖。在年老的(18 个月大)小鼠中,当雌性处于绝经期时,CR 可在两性中减少脂肪量并改善葡萄糖稳态。最后,在超重和肥胖人群的队列中,CR 引起的脂肪减少也存在性别和年龄依赖性:年轻的雌性(<45 岁)比年轻的雄性更抵抗脂肪减少,而在年长的受试者(>45 岁)中这种性别差异不存在。总之,这些研究确定了 CR 代谢作用的年龄相关性别差异,并强调了脂肪组织、肝脏和雌激素是 CR 代谢益处的关键决定因素。这些发现对理解饮食与健康之间的相互作用以及最大限度地提高人类 CR 益处具有重要意义。